Free Alerts   Login
Health Care › Retail-Drug Stores And Proprietary Stores

CVS Stock Price Correlated With CVS Health Financials

CVS Stock Price vs. Quarterly
Income Statement
Cash Flow
Balance Sheet

CVS Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

CVS Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

CVS Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Insider Trading

SEC Form 4
Lynch Karen S   President and CEO
14,000 sh at $70

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Vanguard Group
116,320,394 sh
385,553 sh
State Street
55,022,118 sh
-2,857,185 sh
Capital World Investors
32,633,970 sh
-23,905,817 sh
Morgan Stanley
31,270,495 sh
-2,305,893 sh
Geode Capital Management
22,961,903 sh
-369,195 sh
JPMorgan Chase
22,461,652 sh
-4,232,239 sh
14,492,171 sh
-251,320 sh
13,666,949 sh
3,237,567 sh
Royal Bank Of Canada
13,363,462 sh
13,253,962 sh
Bank Of New York Mellon
12,924,695 sh
-497,053 sh
Goldman Sachs Group
12,756,096 sh
11,972,296 sh
Nordea Investment Management Ab
10,452,356 sh
1,180,537 sh
Legal & General Group Plc
9,492,640 sh
74,348 sh
Price T Rowe Associates /Md/
8,906,771 sh
-1,708,750 sh
Ameriprise Financial
8,649,703 sh
-2,827,356 sh
7,793,304 sh
2,994,990 sh
Boston Partners
7,125,972 sh
-1,580,051 sh
UBS Asset Management Americas
6,635,510 sh
1,209,579 sh
Macquarie Group
5,945,660 sh
85,942 sh
Veritas Asset Management Llp
5,921,949 sh
-67,090 sh
Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of CVS Caremark Corporation and its majority-owned subsidiaries (“CVS Caremark” or the “Company”) have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in Exhibit 13 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 (the “ 2013 Form 10-K”).

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company’s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full fiscal year.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All material intercompany balances and transactions have been eliminated.

Fair Value of Financial Instruments

The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:

Level 1 – Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2 – Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.

Level 3 – Inputs to the valuation methodology are unobservable inputs based upon management’s best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.

As of March 31, 2014 , the carrying value of cash and cash equivalents, short-term investments, accounts receivable and accounts payable approximated their fair value due to the short-term nature of these financial instruments. The Company invests in money market funds, commercial paper and time deposits that are classified as cash and cash equivalents within the accompanying condensed consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. These investments are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Company’s short-term investments consist of certificates of deposit with initial maturities of greater than three months when purchased. These investments, which are classified within Level 1 of the fair value hierarchy, are carried at fair value, which approximated historical cost at March 31, 2014 . The carrying amount and estimated fair value of the Company’

Free historical financial statements for CVS Health Corp.. See how revenue, income, cash flow, and balance sheet financials have changed over 53 quarters since 2010. Compare with CVS stock chart to see long term trends.

Data imported from CVS Health Corp. SEC filings. Check original filings before making any investment decision.